|
| n = 199 | Non-VLCD recipient n = 165 | VLCD recipient n = 34 | P value |
|
| Peritransplantation period |
| Cold ischemia time (minutes), median (IQR) | 114 (76–163) | 83 (56.5–152) | 0.2 |
| Warm ischemia time (minutes), median (IQR) | 47.5 (39.5–61) | 46.5 (41–62) | 0.9 |
| Duration of surgery (minutes), median (IQR) | 557.5 (480–650) | 508.5 (435–600) | 0.09 |
| Graft-to-recipient weight ratio, median (IQR) | 1.1 (1–1.4) | 1.3 (1–1.7) | 0.04 |
| Post-liver transplant period |
| Peak AST post-LT (IU/L), median (IQR) | 552 (300–920) | 419 (238–718) | 0.3 |
| Peak ALT post-LT (IU/L), median (IQR) | 624 (357–946) | 525 (308–745) | 0.3 |
| Peak total bilirubin post-LT (μmol/L), median (IQR) | 110 (73–174) | 118 (73–156) | 0.9 |
| Peak INR post-LT, median (IQR) | 2.2 (1.7–2.6) | 1 (1–1.25) | <0.01 |
| Any complications†, n (%) | 38 (23%) | 11 (32.4%) | 0.3 |
| Biliary stricture, n (%) | 20 (12.1%) | 6 (17.7%) | 0.4 |
| Hepatic thrombosis, n (%) | 5 (3%) | 2 (5.9%) | 0.3 |
| Small-for-size syndrome, n (%) | 1 (0.6%) | 1 (2.9%) | 0.3 |
| Abdominal bleeding, n (%) | 6 (3.6%) | 0 (0%) | 0.6 |
| Need for surgical revision, n (%) | 3 (1.8%) | 0 (0) | 0.6 |
| Infection during hospital stay, n (%) | 9 (5.5%) | 2 (6.1%) | 1 |
| ICU admission, n (%) | 117 (70.9%) | 24 (70.6%) | 1 |
| ICU LOS (days), median (IQR) | 2 (1–4) | 2 (2–4) | 0.8 |
| Hospital LOS (days), median (IQR) | 13 (9–22) | 13 (9–24) | 0.8 |
| 30-day mortality, n (%) | 1 (0.6%) | 1 (2.9%) | 0.3 |
| 90-day mortality, n (%) | 3 (1.8%) | 1 (2.9%) | 0.5 |
| One-year mortality, n (%) | 7 (4.2%) | 1 (2.9%) | 0.6 |
|
